A Randomized, Double-Blind, Placebo-Controlled, Global Phase 3 Study of Edasalonexent in Pediatric Patients with Duchenne Muscular Dystrophy: Results of the PolarisDMD TrialRichard S. Finkel, Joanne M. Donovan, H. Lee Sweeney et al.|Journal of Neuromuscular Diseases|2021Cited by 32